Bonney Lake's wellness culture drives strong interest in GLP-1 treatments. Mounjaro® is the FDA-approved Injectable pen Tirzepatide product manufactured by Eli Lilly. Weight Method offers a separate program for Bonney Lake residents: licensed Washington providers evaluate eligible patients via telehealth and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program starts at $329/month, with the provider evaluation, the medication, ongoing care, and home delivery to Bonney Lake included.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Bonney Lake is already seeing results
GLP-1 weight-loss treatment available to eligible patients in Bonney Lake, WA. Weight Method offers compounded tirzepatide, prescribed by licensed providers, from $329/month with virtual consultations and direct-to-door shipping.
Mounjaro® by Eli Lilly is the FDA-approved Injectable pen Tirzepatide product, taken Once weekly and approved in 2022 for Type 2 diabetes. Tirzepatide works by mimicking incretin hormones that regulate hunger and satiety, reducing appetite and helping you feel full with smaller portions. Weight Method is a separate telehealth program for Bonney Lake residents: licensed providers evaluate eligible patients and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program starts at $329/month and includes the provider evaluation, the medication, ongoing care, and home delivery.
Bonney Lake's suburban communities are hearing more about GLP-1 treatments through word of mouth and national media. Mounjaro® is the FDA-approved Injectable pen Tirzepatide product manufactured by Eli Lilly since 2022. Weight Method's separate program is straightforward: an online assessment, a virtual provider consultation, and compounded Tirzepatide delivered to your Bonney Lake address at $329/month. Compounded Tirzepatide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Washington and start Mounjaro from $329/month.
Get Started NowFree consultation. No commitment.